ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628676 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628676; 2) Community: the network communities that were significantly associated with the response to NSC 628676; 3) Molecule: the relationships between components within communities and NSC 628676; 4) MDR: the compounds that were significantly associated with the NSC 628676.

NSC Compound Enrichment Correlation
NSC 710204 Null 0.0133986477026052 0.27729001
NSC 732841 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3-trifluoromethylbenzene 0.0133986477026052 0.29375966
NSC 744075 Null 0.0133986477026052 -0.012090177
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0139289274573436 -0.025326304
NSC 685685 3-Pyridinecarboxylic acid, 4-[2-cyano-2-(ethoxycarbonyl)-1- (2-phenyhydrazino)ethenyl]- 0.0139289274573436 0.10322789
NSC 8120 Claviform 0.0139289274573436 0.09513155
NSC 682809 Null 0.0139289274573438 -0.23128705
NSC 174121 Methotrexate Derivative 0.0145667015252499 0.41287938
NSC 194350 Acridine Orange 0.0145667015252499 0.35430744
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.01456670152525 0.18391376
Total:66  Current:23    [First] [Prev] [Next] [Last]